Fesoterodine Fumarate
NDC 67877-064, Fesoterodine Fumarate, tablet, extended release, from Ascend Laboratories, LLC.
- Product NDC
- 67877-064
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204827
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67877-064 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FESOTERODINE FUMARATE4 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-064-30 | 67877006430 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-064-30) |
| 67877-064-90 | 67877006490 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-064-90) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b1abd9cb-c480-437b-8531-e2de3e188363NADAC price for package 67877006430
GET /v1/drugs/nadac/67877006430
Use it
Look up 67877-064 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-064 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-064. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.